Favipiravir in SARS-CoV-2 infection: Is it Worthwhile? - DocWire News

4/18/2022 12:00:00 AM3 years 10 months ago

Comb Chem High Throughput Screen. 2022 Apr 14. doi: 10.2174/1386207325666220414111840. Online ahead of print.ABSTRACTFavipiravir is a potential antiviral

Comb Chem High Throughput Screen. 2022 Apr 14. doi: 10.2174/1386207325666220414111840. Online ahead of print. ABSTRACT Favipiravir is a potential antiviral drug undergoing clinical trials to manage… [+1334 chars]

full article...